Get the Stockscreener App
4.205
3.00%
-0.125
Savara Inc stock is traded at $4.205, with a volume of 749.03K.
It is down -3.00% in the last 24 hours and up +24.63% over the past month.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
See More
Previous Close:
$4.33
Open:
$4.32
24h Volume:
749.03K
Relative Volume:
0.49
Market Cap:
$725.92M
Revenue:
-
Net Income/Loss:
$-54.70M
P/E Ratio:
-12.74
EPS:
-0.33
Net Cash Flow:
$-51.36M
1W Performance:
+4.22%
1M Performance:
+24.63%
6M Performance:
+39.07%
1Y Performance:
+9.66%
1-Day Range:
$4.19
$4.40
1-Week Range:
$3.86
$4.40
52-Week Range:
$1.89
$4.505
Savara Inc Stock (SVRA) Company Profile
Name
Savara Inc
Sector
Industry
Phone
51285113796
Address
6836 BEE CAVE ROAD, AUSTIN, TX
Compare SVRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
4.20 | 805.21M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.68 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.30 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.28 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
899.16 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.25 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Nov-13-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-24 | Initiated | JMP Securities | Mkt Outperform |
| Nov-07-23 | Initiated | Guggenheim | Buy |
| May-16-23 | Upgrade | Jefferies | Hold → Buy |
| Mar-31-23 | Downgrade | Jefferies | Buy → Hold |
| Mar-16-21 | Initiated | Piper Sandler | Overweight |
| Mar-15-21 | Initiated | Oppenheimer | Outperform |
| Jun-13-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-13-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-13-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Aug-13-18 | Resumed | ROTH Capital | Neutral |
| Jan-03-18 | Initiated | Ladenburg Thalmann | Buy |
| Sep-27-17 | Resumed | ROTH Capital | Buy |
| Sep-22-17 | Initiated | Jefferies | Buy |
| Sep-11-17 | Initiated | JMP Securities | Mkt Outperform |
View All
Savara Inc Stock (SVRA) Latest News
Is Savara Inc. stock attractive for income investors2025 Geopolitical Influence & Low Risk High Reward Ideas - newser.com
SAVARA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Savara Stockholders to ... - Black Hills Pioneer
Volatility clustering patterns for Savara Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Savara Secures $75 Million Royalty Deal to Back Potential MOLBREEVI Launch - MyChesCo
Reviewing Savara (NASDAQ:SVRA) & Guardian Pharmacy Services (NYSE:GRDN) - Defense World
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders - Morningstar
Shareholders SueWallSt in New Class Action Against Savara Inc.Act Now - Nasdaq
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - cnhinews.com
Savara Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Savara Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSVRA - MarketScreener
Investor Alert: Deadline Approaching to Join Savara Inc. (SVRA) Class ActionContact Levi & Korsinsky - Stockhouse
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Shareholders that lost money on Savara Inc.(SVRA) should contact Levi & Korsinsky about ... - Bluefield Daily Telegraph
Shareholders that lost money on Savara Inc.(SVRA) should - GlobeNewswire
Levi & Korsinsky Releases SueWallSt Podcast on Savara Inc. (SVRA) Lawsuit - ACCESS Newswire
Will Savara Inc. stock rally after Fed decisionsJuly 2025 Retail & Free AI Powered Buy and Sell Recommendations - newser.com
Multi asset correlation models including Savara Inc.Weekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Deadline Soon: Savara Inc. (SVRA) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The Globe and Mail
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SVRA ALERT: Securities Fraud Class Action Launched Against Savara Inc.November 7, 2025 Deadline - Stockhouse
SAVARA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently - GlobeNewswire
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Savara - MarketScreener
Why Savara Inc. stock could outperform in 20252025 Technical Patterns & Safe Capital Preservation Plans - newser.com
November 7, 2025 Deadline Approaching: Join Class Action Against Savara Inc. (SVRA)Contact Levi & Korsinsky - Stockhouse
Holdings of Savara Inc (SVRA) are aligned with the stars - setenews.com
Shareholders of Savara Inc. Should Contact The Gross Law Firm Be - GuruFocus
Shareholders of Savara Inc. Should Contact The Gross Law Firm Before November 7, 2025 to Discuss Your RightsSVRA - PR Newswire
How strong dollar benefits Savara Inc. (YB4P) stockEarnings Trend Report & Technical Buy Zone Confirmation - newser.com
Is Savara Inc. stock safe for conservative investorsWeekly Stock Recap & AI Powered Market Trend Analysis - Fundação Cultural do Pará
Short interest data insights for Savara Inc.2025 Price Momentum & Community Driven Trade Alerts - newser.com
SVRA DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Savara Inc. Investors ... - Bluefield Daily Telegraph
SVRA DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, - GlobeNewswire
Is Savara Inc. (YB4P) stock in buy zone after pullbackTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Why analysts recommend Savara Inc. (YB4P) stockWeekly Stock Analysis & Consistent Return Investment Signals - Fundação Cultural do Pará
Portnoy Law Firm Announces Class Action on Behalf of Savara, Inc. Investors - GlobeNewswire
Savara (SVRA) Expected to Announce Earnings on Tuesday - MarketBeat
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2025 in Savara Inc. LawsuitSVRA - WV News
Burned by Savara Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Savara Inc. (SVRA) Investors of November 7, 2025 Deadline - The Globe and Mail
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire
SueWallSt Podcast Explains Class Action Against Savara Inc. (SVRA) - ACCESS Newswire
What Does Wall Street Think About Savara Inc. (SVRA)? - MSN
Savara Inc. stock momentum explained2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
Savara Hit with Class Action Over Molbreevi Misrepresentations - TipRanks
Is Savara Inc. (YB4P) stock supported by free cash flowJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Latham & Watkins Advises RTW Investments in US$75 Million Royalty Funding Agreement With Savara - Legal Desire Media and Insights
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class ActionSVRA - Lelezard
Savara Announces Participation in Upcoming Investor Healthcare Conferences - MarketScreener
Savara Inc Stock (SVRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Savara Inc Stock (SVRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director |
May 29 '25 |
Buy |
2.08 |
10,000 |
20,825 |
260,837 |
| RAMSAY DAVID A | Director |
Mar 31 '25 |
Buy |
2.77 |
150,000 |
416,250 |
2,513,642 |
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
1.72%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):